Partner Institutions

Acknowledgments

The Collaborative Research, Implementation, and Leadership Training to Address Chronic Conditions Across the LifeCourse (COALESCE) is a collaboration between Emory University’s Rollins School of Public Health, Center for Chronic Disease (CCDC) India, and Addis Ababa University (AAU). This consortium was established through the Fogarty International Center of the US National Institutes of Health grant #D43TW011404

Participating Institutions

Emory University, Atlanta, Georgia USA (https://www.sph.emory.edu) is recognized as one of the nation’s leading research universities and is ranked 21st of national universities according to U.S. News & World Report (2020).  Rollins School of Public Health (RSPH) at Emory University is ranked fifth among public health graduate schools by U.S. News & World Report (2020) and is comprised of six academic departments: global health, behavioral sciences and health education, biostatistics, environmental health, epidemiology, and health policy and management, and hosts over two dozen interdisciplinary centers.

RSPH location in Atlanta, referred to as the “Public Health Capital of the World” , is home to the headquarters of the U.S. Centers for Disease Control and Prevention (CDC) as well as numerous international, state and regional health agencies and non-governmental organizations.

Addis Ababa University (AAU), Addis Ababa, Ethiopia (http://www.aau.edu.et), was established in 1950 as the University College of Addis Ababa (UCAA), is the oldest and the largest higher learning and research institution in Ethiopia. Since its inception, the University has been the leading center in teaching-learning, research and community services.

AAU has been undertaking various reform schemes in order to cope with and respond to the fast-changing national and international educational dynamics. AAU has 10 colleges, 4 institutes that run both teaching and research, and 6 research institutes that predominantly conduct research.

Centre for Chronic Disease Control (CCDC), New Delhi, India (http://www.ccdcindia.org) is a not-for-profit organization, established in December 2000. The mission of CCDC is primarily intended to address the growing challenge of chronic diseases, in varied settings of developing countries. CCDC has been recognized as a Scientific and Industrial Research Organization (SIRO) by Department of Scientific & Industrial Research (DSIR), Ministry of Science and Technology, Government of India. It also holds registration under Foreign Contribution (Regulation) Act, 1976.

The research work at CCDC has produced major insights into the epidemiology, developmental origin, and biomarkers of CVD and diabetes in India; practice patterns on Acute Coronary Syndrome; translation research in CVDs; and development of low-cost combination drugs for primary and secondary prevention of CVDs in South Asia. CCDC holds recognition as a ‘Centre of Excellence in Clinical Research’ from the Clinical Development Service Agency (CDSA), Department of Biotechnology, Government of India. It is also a WHO Collaborating Centre for Surveillance, Capacity building and Translational Research in Cardio-Metabolic Diseases.